A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes

Abstract Background Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to β-interferon. It acts against CD52, leading primarily to lymphopenia. Recent data have shown that mild neutropenia is observed...

全面介紹

書目詳細資料

Principais autores:	A. G. Vakrakou, D. Tzanetakos, S. Valsami, E. Grigoriou, K. Psarra, J. Tzartos, M. Anagnostouli, E. Andreadou, M. E. Evangelopoulos, G. Koutsis, C. Chrysovitsanou, E. Gialafos, A. Dimitrakopoulos, L. Stefanis, C. Kilidireas
格式:	Artigo
語言:	Inglês
出版:	BMC 2018-10-01
叢編:	BMC Neurology
主題:	Multiple sclerosis Alemtuzumab Neutropenia Large granular cells
在線閱讀:	http://link.springer.com/article/10.1186/s12883-018-1183-4
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!